MARKET WIREMoomoo • 7h ago
Definitive Healthcare(DH) Stock Options Chain | Quotes & NewsMoomoo report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
Why DH Stock Traded Steady Today — RQD Quant Desk Flash
$1.12 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.12
Definitive Healthcare Corp. (Class A) (DH) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $162.4M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on DH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Definitive Healthcare Corp. (Class A) (NASDAQ: DH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.12 (0.00% 1D, market cap $162.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, DH ranks #384 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DH compare to SWMR and EGAN in the Technology sector?
▼
Within the Technology sector (Computer Software: Prepackaged Software), DH carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 75.9%, and ROIC of -35.0%. By comparison, SWMR (Swarmer Inc) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $167.4M) and EGAN (eGain Corporation) posts a C- grade (59/100 RQD, P/E 4.7x, ROIC 46.7%, cap $150.1M). Among the 5-stock peer group, EGAN leads on earnings multiple (4.7x) while EGAN leads on capital efficiency (46.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DH?
▼
Per DH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861795), Definitive Healthcare Corp. (Class A) generated $241.5M in revenue (-4.2% YoY), -$138.9M in net income, and $37.1M in free cash flow against $735.5M in total assets and $156.1M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.12 (-0.19%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 15.3% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-4.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DH)Realized 20D OHLCV Swing Band: ±10.8%
Deterministic 5-Pillar Attribution (48/100 Composite)
🔍 WHY DH SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+12/20 pts (25% of score)
FRED Regime × Technicals: 21% of 52W Range • RSI-14 at 63.9 (BULLISH MOMENTUM)
▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (23% of score)
20D Institutional Volume Accumulation (±10.8% realized swing band)
▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)
Capital intensity & 0% operating margin leave 16 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$0.98+12.2% Next Q
40
Q2 (-2Q)Grade D$1.10-1.8% Next Q
43
Q3 (-1Q)Grade D$1.08+3.7% Next Q
45
CurrentGrade D$1.12-5.6% Hist 90D α
48
Trajectory: D (40) → D (48)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a DH Turnaround Squeeze
While DH currently carries a cautious 48/100 (D) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Technology with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.99) and Max Pain ($1.18) forces dealer call-delta covering toward $3.15.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.96% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $DH• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “DH Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why DH Stock Traded Steady Today — RQD Quant Desk Flash
Definitive Healthcare Corp. (Class A) (DH) slipped 0.00% to $1.12, trading at 21% of its 52-week range ($0.61 – $3). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 21% of its 52-week range ($0.61 – $3) with RSI-14 at 63.9 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±10.8% around $1.12 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 75.9% gross margin and $37.1M annual free cash flow.
Live DH Headlines & Catalysts
MARKET WIREStock Titan • 10h ago
Tax withholding leaves Definitive Healthcare (DH) legal chief with 864,534 shares.Stock Titan report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 13h ago
DH Q3'26 Earnings: revenue estimate is 54.57M USDTradingView report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
CATALYSTSimply Wall St • 16h ago
Learn Why The Bull Case For Veeva Systems Stock Could Change Following IQVIA Clinical Tool StandardizationSimply Wall St report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 19h ago
Most Active Stocks Today: U.S. MarketTradingKey report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESimply Wall Street • 22h ago
Veeva Systems (VEEV) Could Be 16% Undervalued As IQVIA And AI News Draw FocusSimply Wall Street report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESimply Wall St • 1d ago
How Investors May Respond To Veeva Systems Stock As AI Adoption GrowsSimply Wall St report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESimply Wall St • 1d ago
Is Veeva Systems (VEEV) Undervalued As Its Share Price Tests Fresh Highs?Simply Wall St report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DH)
- ✓Walkthrough of DH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
DH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.74%📐 HORIZONTAL RANGE
2026-11-02O $1.14H $1.14L $1.12C $1.12VOL 335.8K
RES: $1.21SUP: $0.59SMA50: $0.99SMA200: $1.07
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
DH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -4.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on DH today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for DH. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DH)
Technology Rank #384 of 714
⚔️ SWMR vs DH Full Matrix →
1. Head-to-Head Technology Peer Comparison (DH vs. SWMR, EGAN, HUCK, AEYE)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, Definitive Healthcare Corp. (Class A) (DH) ranks #384 by composite RQD confidence (48/100, grade D) and #498 by equity capitalization ($162.4M). Within this direct 5-issuer industry benchmark cohort, EGAN leads on earnings valuation at 4.7x trailing P/E, while EGAN leads on capital efficiency and profitability with 46.7% ROIC and 70.1% gross margin. EGAN currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with DH at 48/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DH
ACTIVE
Definitive Healthcare Corp. (Class A) | D | 48/100 | — | 75.9% | -35.0% | 0.00% | $162.4M | Benchmark Subject |
| SWMR Swarmer Inc | E | 26/100 | — | 41.2% | -35.0% | -4.97% | $167.4M | /swmr-vs-dh → |
| EGAN eGain Corporation | C- | 59/100 | 4.7x | 70.1% | 46.7% | -0.51% | $150.1M | /egan-vs-dh → |
| HUCK Huckleberry.ai Inc. (Class B) | E | 29/100 | — | 75.0% | -35.0% | +0.32% | $147.7M | /huck-vs-dh → |
| AEYE AudioEye Inc. | D | 46/100 | — | 78.3% | -12.1% | -7.72% | $179.1M | /aeye-vs-dh → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001861795In its most recent audited fiscal period (FY2025, filed 2025-12-31), Definitive Healthcare Corp. (Class A) (DH) reported GAAP revenue of $241.5M (-4.2% vs. FY2024 revenue of $252.2M , and -3.9% cumulative change since FY2023) , GAAP net income of -$138.9M, operating cash flow of $53.8M, and free cash flow of $37.1M (-19.2% YoY). On the balance sheet, DH closed FY2025 with $735.5M in total assets against $156.1M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $241.5M | -$138.9M | $53.8M | $37.1M | $735.5M | $156.1M |
| FY2024 (FY) | 2024-12-31 | $252.2M | -$413.1M | $58.2M | $45.9M | $1.09B | $229.4M |
| FY2023 (FY) | 2023-12-31 | $251.4M | -$202.4M | $41.2M | $41.2M | — | — |
3. DH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Definitive Healthcare Corp. (Class A) (NASDAQ: DH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.12 (0.00% 1D, market cap $162.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, DH ranks #384 in composite RQD confidence.
How does DH compare to SWMR and EGAN in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), DH carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 75.9%, and ROIC of -35.0%. By comparison, SWMR (Swarmer Inc) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $167.4M) and EGAN (eGain Corporation) posts a C- grade (59/100 RQD, P/E 4.7x, ROIC 46.7%, cap $150.1M). Among the 5-stock peer group, EGAN leads on earnings multiple (4.7x) while EGAN leads on capital efficiency (46.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DH?
Per DH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861795), Definitive Healthcare Corp. (Class A) generated $241.5M in revenue (-4.2% YoY), -$138.9M in net income, and $37.1M in free cash flow against $735.5M in total assets and $156.1M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DH trading relative to its 50-day, 200-day, and 52-week technical levels?
DH last traded at $1.12 (0.00% on volume of 447,913 shares), positioning the stock +13.13% above its 50-day simple moving average ($0.99) and +4.67% above its 200-day simple moving average ($1.07). Across its 52-week range of $0.61 to $3.00, DH sits at the 21.3% percentile with a 14-day RSI of 63.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±10.8% ($1.00 to $1.24).
DH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is DH stock moving today?
Why DH Stock Traded Steady Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 48/100 (D)
✓ STAGE-C NUMBER FIREWALL VERIFIED
DH — Definitive Healthcare Corp. (Class A): What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:42:22Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, DH scores 48 out of 100, grade D, labeled "Roarable Sell — Underperform / Distribution Warning." The five pillars are:
- Fundamental Cash Engine: 4 / 20. Per the RQD rating, ROIC is -35% and FCF yield is 22.82%. For a prospective investor, the weak ROIC indicates the company is not currently earning returns on invested capital, while the high FCF yield is a positive cash-generation signal that the rating weighs only lightly against the profitability deficit.
- Whale 13F Flow: 11 / 20. The rating reflects institutional accumulation and options positioning at a moderate level. Holder-level detail is not available in source data, so the specific direction of institutional flows cannot be confirmed here.
- Insider Conviction: 11 / 20. The rating reflects SEC Form 4 and Congressional PTR cluster flow at a moderate level. Individual transaction records are not available in source data.
- Macro Regime Fit: 12 / 20. Per the RQD rating, beta is 1.0 and the score reflects sector sensitivity. A beta of 1.0 implies market-level sensitivity to broad moves, which means DH's price may track the overall market rather than offering defensive or differentiated behavior.
- Forensic Balance Sheet: 10 / 20. Per the RQD rating, Altman Z is 0.2, Piotroski F is 7/9, and Debt/Equity is 0.41. The low Altman Z is a distress-zone signal, partly offset by a relatively strong Piotroski reading and moderate leverage.
Taken together, the rating points to a stock whose cash generation and balance sheet mix is the most mixed element, while profitability and distress metrics weigh heavily on the overall score. A prospective investor should treat the Roarable rating as an analytical framework that summarizes these tradeoffs, not as a recommendation to buy or sell.
Business
Definitive Healthcare Corp. (Class A) is a NASDAQ-listed issuer in the Technology sector, operating in the Computer Software: Prepackaged Software industry, per the company profile. The source data does not describe its specific products, customer base, or revenue model. Per the market data, gross margin is 75.9%, indicating a high-margin software revenue profile, though the source data does not confirm the underlying business mechanics.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $241.5M | $-224.3M | $-138.9M | N/A | $37.1M | $163.6M | $156.1M |
| FY 2024 | $252.2M | $-710.8M | $-413.1M | N/A | $45.9M | $105.4M | $229.4M |
| FY 2023 | $251.4M | $-329.8M | $-202.4M | N/A | $41.2M | N/A | N/A |
Per the SEC financials, revenue has been broadly flat across the three reported years, moving from $251.4M to $252.2M to $241.5M, while operating and net losses have been substantial in each period. Per the market data, operating margin is -60%, net margin is -57.5%, and ROIC is -35%. The RQD rating reports an Altman Z-Score of 0.2 and a Piotroski F-Score of 7/9, and a Debt/Equity ratio of 0.41. Reported cash rose from $105.4M in FY 2024 to $163.6M in FY 2025, while debt declined from $229.4M to $156.1M over the same period.
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts section, the most recent items are largely market-wire and aggregator reports. One item is flagged as a CATALYST and concerns Simply Wall St coverage of Veeva Systems and IQVIA; this relates to a peer rather than to DH directly. A TradingView item cites a Q3'26 revenue estimate of 54.57M USD for DH. A Stock Titan item reports that a legal chief received 864,534 shares following tax withholding. The remaining items are generic market-activity and positioning summaries with no company-specific detail. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded for DH.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. The source data therefore does not identify upstream suppliers, downstream customers, or sector correlations. Based strictly on the sector and industry classification, the peer references in the news wire (Veeva Systems and IQVIA) are the only related names mentioned, and the source data does not describe the nature of any dependency. A prospective investor should watch for any future disclosure of customer concentration or supplier dependency, though none is available in the current source data.
Open Questions
- What are the company's specific products, customers, and revenue model, given that the source data describes only the sector and industry?
- What drove the FY 2024 operating loss of $-710.8M, and what portion is non-recurring versus ongoing?
- Why are FY 2025 and FY 2024 EPS values listed as N/A, and what is the share count underlying the $162.4M market capitalization?
- What is the cash burn and liquidity runway, given Altman Z-Score of 0.2 and the reported cash and debt levels?
- What does the $0.61 to $3 52-week range reflect in terms of company-specific events?
DH Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Definitive Healthcare Corp. (Class A) (DH) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Moomoo • 7h ago
Definitive Healthcare(DH) Stock Options Chain | Quotes & News Moomoo report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 10h ago
Tax withholding leaves Definitive Healthcare (DH) legal chief with 864,534 shares. Stock Titan report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 13h ago
DH Q3'26 Earnings: revenue estimate is 54.57M USD TradingView report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Simply Wall St • 16h ago
Learn Why The Bull Case For Veeva Systems Stock Could Change Following IQVIA Clinical Tool Standardization Simply Wall St report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 19h ago
Most Active Stocks Today: U.S. Market TradingKey report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall Street • 22h ago
Veeva Systems (VEEV) Could Be 16% Undervalued As IQVIA And AI News Draw Focus Simply Wall Street report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall St • 1d ago
How Investors May Respond To Veeva Systems Stock As AI Adoption Grows Simply Wall St report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Simply Wall St • 1d ago
Is Veeva Systems (VEEV) Undervalued As Its Share Price Tests Fresh Highs? Simply Wall St report covering Definitive Healthcare Corp. (Class A) (DH) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
DH Bull vs. Bear Conversation Board — What's Your Call at $1.12?
🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DH 🐻 50% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST
🎯 Target: $1.21 (+8.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is DH (D • RQD 48/100) a Buy at $1.12?
Welcome to the DH (Definitive Healthcare Corp. (Class A)) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell — Underperform / Distribution Warning) in Computer Software: Prepackaged Software. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $0.90 (-19.6%)
Spot @ $1.12 Pump the brakes on DH — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on DH, but look at what you are paying: current EV/EBITDA multiples with 75.9% gross margins. Unless Definitive Healthcare Corp. (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
MI MidwestValue Verified K Arena Trader 🐂 BULLISH
🎯 Target: $1.43 (+27.7%)
Spot @ $1.12 DH cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on DH, the market is fixating on short-term headline noise in Computer Software: Prepackaged Software and ignoring the balance sheet and cash flow trajectory. At $1.12 (52-wk range $0.61 - $3.00), any beat on forward guidance forces shorts and underweight funds to chase.